Danimer Scientific, Inc (NYSE:DNMR) Q2 2024 Results Conference Call August 8, 2024 4:30 PM ET

Company Participants

Blake Chamblee - Director of Financial Reporting
Stephen Croskrey - Chairman and Chief Executive Officer
Mike Hajost - Chief Financial Officer

Conference Call Participants

Jon Tanwanteng - CJS Securities

Operator

Greetings. Welcome to the Danimer Scientific 2024 Second Quarter Earnings Call. [Operator Instructions] Following the presentation, we will conduct a question-and-answer session. [Operator Instructions]. This call is being recorded on Thursday, August 8, 2024.

I would now like to turn the presentation over to Mr. Blake Chamblee, the company's Investor Relations representative.

Blake Chamblee

Thank you, operator. Good afternoon, everyone, and thank you for joining us today for Danimer Scientific's 2024 Second Quarter Earnings Call. Leading the call today are Steve Croskrey, Chief Executive Officer; and Mike Hajost, Chief Financial Officer.

I'd like to note the slide deck that accompanies today's discussion, which is available on the Investor Relations section of our website danimerscientific.com. As we begin, I'll call your attention to the company's safe harbor language, which is published in our SEC filings and on Slide 2 of the presentation I just referenced.

On today's call, we may discuss forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. Forward-looking statements, among other things, statements regarding future results of operations, including margins, profitability, capacity, production, customer programs and market demand levels. Actual results could differ materially from what is expressed or implied in our forward-looking statements.

The company assumes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law. Today's presentation also includes references to non-GAAP financial measures within the meaning of SEC Regulation G. We believe these non-GAAP measures have analytical value but note that they should be taken as supplementary measures of performance and not as alternatives to GAAP results. We have provided reconciliations for non-GAAP financial measures to the most comparable GAAP financial measures in our earnings release and our presentation. Thank you.

And it's now my pleasure to turn the call over to Steve Croskrey, Chief Executive Officer of Danimer Scientific.

Stephen Croskrey

Good afternoon, and thank you for joining us. Before I get into the second quarter results, I'd like to step back and take a moment to discuss what we originally set out to do many years ago, where we are today and how we see our business shaping up in the near future.